ASCO Unveils Decision Support System

Article

"...But CancerLinQ, a project of ASCO's Institute for Clinical Excellence, is still in the testing stages. ASCO plans to publish information on the system in coming year, and use knowledge gained to develop the full CancerLinQ system.
"We talk about getting second opinions," Charles Penley, MD, of Tennessee Oncology in Nashville, said. "This will be second opinions times multiples."
Just 3% of cancer patients enter clinical trials -- the main data set oncologists use for evidence-based guidelines. CancerLinQ would tap the remaining 97%, supporters here said.....